Avira Resources Limited (ASX:AVW) has advised that all four resolutions put to shareholders at its Annual General Meeting held on 19 November 2026 were passed by the requisite majority, including the adoption of the remuneration report, re-election of a director, approval of a share issuance mandate, and renewal of proportional takeover provisions.
Key Points
- All four resolutions put to shareholders at the 19 November 2026 Annual General Meeting were passed by the requisite majority.
- Resolution 1, adoption of the remuneration report, was passed with 100% of poll votes cast in favour.
- Resolution 2, re-election of Mr David Deloub as a director, was passed with 99.80% of poll votes cast in favour.
- Resolution 3, approval of a 7.1A mandate, and Resolution 4, renewal of proportional takeover provisions, were also passed on a poll.
Remuneration Report and Director Re-Election Results
Resolution 1, the adoption of the remuneration report, was decided by poll with 131,633,400 proxy votes exercisable by validly appointed proxies. All 131,633,400 of those votes were cast in favour, representing 100% of votes cast, with 280,000 votes recorded as abstentions. Resolution 2, the re-election of Mr David Deloub as a Non-Executive Director, was also decided by poll. Of the 139,663,400 proxy votes exercisable, 139,633,400 votes, or 99.80%, were cast in favour, with 280,000 votes, or 0.20%, cast against.
Approval of 7.1A Mandate and Proportional Takeover Provisions
Resolution 3, seeking approval of a 7.1A mandate, was decided by poll with 139,663,400 proxy votes exercisable. Of those, 139,633,400 votes, representing 99.80%, were cast in favour and 280,000 votes, representing 0.20%, were cast against. Resolution 4, the renewal of proportional takeover provisions, was also determined by poll with 139,663,400 proxy votes exercisable. A total of 139,593,400 votes, or 99.77%, were cast in favour, while 320,000 votes, or 0.23%, were cast against.
Issued Capital and Company Officers
According to the filing, Avira Resources Limited has 575,000,000 ordinary shares on issue, along with 270,781,470 quoted options exercisable at $0.015 on or before 30 June 2027. The company also has 20,125,001 unquoted options exercisable at $0.06 on or before 30 June 2027, and 25,000,000 unquoted options exercisable at $0.015 on or before 31 December 2027. The company's officers include David Wheeler as Non-Executive Chairman, James Robinson as Executive Director, David Deloub as Non-Executive Director, Andrew van Bentum as Chief Executive Officer, and Rhys Waldon as Company Secretary.




Please wait processing your request...